NO-STRESS · Nitric oxide regulation of repolarisation in the heart: role of mechanical stress
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2018-09-30 → 2020-09-29
- Финансиране от ЕС
- 195 455 €
- Участници
- 1
- Схема
- MSCA-IF-EF-ST
Линиите свързват координатора с партньорите.
Накратко на български
Сърдечните клетки се изследват, за да се разбере как азотният оксид регулира работата на протеините (йонните канали), които контролират електрическите им сигнали. Това помага за разбирането на предсърдното фибрилация – състояние с неправилен ритъм, което увеличава риска от инсулт.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Nitric oxide regulation of repolarisation in the heart: role of mechanical stress
The muscle cells of the heart are called cardiomyocytes. When the heart beats, all the cardiomyocytes contract at the same time, leading to smooth movement of blood through the heart. Cardiomyocyte contraction occurs when electrical impulses trigger an electrical signal in the cardiomyocyte called an action potential. The action potential is the signal to make the cell contract, and is generated by tiny electrical currents flowing through specialised proteins called ion channels. Ion channels open in a specific sequence, and alterations in this sequence can lead to perturbations in the action potential, which can disrupt the synchronous contraction of cardiomyocytes. This is called fibrillation (irregular heart beat). Atrial fibrillation (AF) is the most common arrhythmia, and is a leading risk factor for stroke when blood clots forming in the atria travel to the brain. At the atrial cardiomyocyte level, changes in atrial electrical activity as a result of differences in the expression and function of ion channels are hallmark features of AF. The ion channel Kv1.5 contributes to the length of the action potential (AP), and as such, directly affects action potential duration (APD). Changes in APD occur early in the pathology of AF. Because of its atrial-specific localisation , Kv1.5 may be a target for AF therapies. Another feature of AF is a decrease in the enzyme neuronal nitric oxide synthetase, which produces nitric oxide (NO). There is growing evidence that NO can alter the activity of Kv1.5. This project was conducted to investigate how this regulation occurs in human cardiomyocytes, and whether this is altered in AF, a condition in which NO is depleted. In addition, mechanical regulation of cardiomyocyte electrical activity is receiving increasing attention as contributing factor in various cardiac pathologies where the mechanical environment is altered (including atrial fibrillation). As NO has been shown to be increased by mechanical stress, we wished to investigate whether mechanical regulation of Kv1.5 is altered by NO, as well as investigating the role of the recently characterised mechanically gated ion channel Piezo-1. Increased knowledge in these areas will contribute to our understanding of AF, and may highlight new therapeutic targets. The specific objectives were: i) To investigate the mechanisms underlying the regulation of Kv1.5 by nNOS in human atrial myocytes from patients with and without AF. ii) To understand how mechanical stress is linked to NO production and altered repolarisation in human physiology and AF. iii) Investigate the role of the mechanically activated ion channel Piezo-1 in atrial cardiomyocytes
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Atrial fibrillation (AF) is a leading risk factor for stroke and is a growing public health burden. The condition is associated with pronounced electrical remodelling of the atria and can prove challenging to treat. A potential target for AF therapies is the repolarising potassium current IKur, carried by the atrial specific ion channel Kv1.5. This channel is not found in the ventricles and therefore provides an attractive therapeutic target for the treatment of AF. In atrial myocytes isolated from patients in AF we have shown an increase in IKur, as well as a reduction in the expression of neuronal nitric oxide synthase (nNOS). Inhibition of nNOS in mycoytes from patients in sinus rhythm recapitulated the AF phenotype. Kv1.5 is also modulated by mechanical stress, which has been shown to affect NO production in myocytes. We have shown that shear stress recruits Kv1.5 from an intracellular pool to the cell surface, leading to an increase in IKur. This proposal aims to investigate mechanism by which nNOS regulates IKur. We hypothesise that mechanical stress (likely modified in AF) will result in altered nNOS regulation of Kv1.5 in human myocytes. We will go on to investigate how nNOS regulation of Kv1.5 is dysregulated in AF. A multi-disciplinary approach will be used employing a) human mycoytes isolated from patients, b) an nNOS knockout (-/-) mouse and c) cardiomycoytes overexpressing GFP-Kv1.5. Whole cell currents from isolated myocytes will be measured electrophysiologically, and IKur pharmacologically dissected. A range of biochemical techniques will be employed to investigate the physical interactions between nNOS and Kv1.5. Conventional and TIRF microscopy will be used to examine the localisation of Kv1.5 and partner proteins when nNOS activity is inhibited, or where the nNOS protein is absent (nNOS-/-). This translational study will improve our understanding of ion channel regulation in AF and may identify important new targets for AF therapies.
Оригинален текст от CORDIS (на английски).
Участници
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD · OxfordКоординаторОбединеното кралство
Връзки
- Виж в CORDIS
- DOI: 10.3030/746208
- https://www.rdm.ox.ac.uk/about/our-divisions/division-of-cardiovascular-medicine/division-of-cardiovascular-medicine-research/translational-approaches-in-chronic-cardiac-disease
Данни: CORDIS, © Европейски съюз
